U.S. federal trademark · Serial No. 97642362 · Reg. No. 321045
Development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
Chemical, biological and biochemical preparations and reagents for the cultivation of human immune cells, in particular T cells, for medical purposes in the treatment of immuno-oncological diseases; Human immune cells, in particular T cells, for medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cells, in particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases
Medical services related to the treatment and preparation of human cells; medical services, namely, immune cell therapy; medical services, namely, immune cell modification; medical services, namely, administration of immune cells; medical consulting related to immune cell therapy, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
Contract manufacturing of therapeutic medicinal products, namely, Contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
Human immune cells, in particular T cells, for scientific and medical research
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.